Abstract

Introduction: Microscopic colitis (MC) is a chronic inflammatory disease of the colon causing frequent watery diarrhea, abdominal pain, nocturnal diarrhea, urgency and fecal incontinence. Once known to be rare now MC is one of the most common causes of chronic watery diarrhea in adult population which leads to poor quality of life and increase health care cost burden. So, we decide to identify baseline characteristics and incidence of microscopic colitis in adult population. Methods: Adult patients admitted with MC were analyzed from 2016 - 2019 using the National Inpatient Sample database. The primary outcome was to determine the baseline characteristics of patients admitted with MC. Secondary outcome was to determine the disease burden in hospitalized patient population. SAS 9.4 software was used for statistical analysis. (Figure) Results: Total 35,685 patients were admitted with MC during our study period. MC cohort comprise of predominantly elders, with mean age of 71.2 ± 13.7 yrs. MC was found to be more prevalent in Caucasian (89.6%) females (77.4%) compared to male (22.6%). We also observed significant increasing trend in hospitalization secondary to MC through 2016 to 2019. Comorbidities like hypertension (62.8%), coronary artery disease (25.3%), smoking (44.7%), hypothyroidism (25.2%) and Depression (24.8%) are some of the higher prevalent ones associated with MC. Concurrent IBS (2.4%), Celiac Disease (2.6%), Rheumatoid Arthritis (9.3%) and C.diff infection (4.5%) were noted among MC patients. Majority of the hospitalization were noted to be emergent (86.7%) and primary insurance in majority of the hospitalized was found to be Medicare (74.5%). (Table) Conclusion: Our study showed increasing prevalence of MC among the elderly, Caucasians and females throughout the study period. Study also showed increased association between depression and MC. Throughout the years MC has shown an increasing hospitalization trend which potentially increases healthcare cost burden. More detailed studies are warranted in this field to better understand pathophysiology, immune response, gut microbiome along with disease management to improve quality of life among MC patients and decrease the health care cost burden especially on Medicare.Figure 1.: Trend of Microscopic Colitis Table 1. - Baseline characteristics and comorbidities of Microscopic colitis patients admitted between January 2016 and December 2020 Microscopic colitis N = 35,685 Age, in years (Mean ± SD*) 71.2 ± 13.7 Age groups, % 18 - 34 years 1.9% 35 – 49 years 5.9% 50 – 64 years 18.3% 65 - 79 43.3% >79 years 30.4% Gender, % Male 22.6% Female 77.4% Race, % Caucasians 89.6% African Americans 2.5% Others 7.9% Comorbidities, % Hypertension 62.8% Diabetes mellitus 18.7% Congestive heart failure 18.4% CAD* 25.3% Peripheral vascular disease 9.3% COPD* 25.1% Renal failure 19.8% Coagulopathy 6.1% Obesity 9.9% Drug abuse 2.1% Alcohol abuse 4.1% Smoking 44.7% Cdiff * infection 4.5% IBS* 2.4% Celiac disease 2.6% Rheumatoid arthritis/collagen vascular disease 9.3% Hypothyroidism 25.2% Depression 24.8% Admission Type, % Emergent 86.7% Elective 13.3% Insurance type, % Medicare 74.5% Medicaid 4.7% Private 18.4% Other 2.4% Location/Teaching status of the hospital, % Rural 8.9% Urban nonteaching 20.7% Urban teaching 70.3% *Abbreviations (SD - Standard deviation, CAD - Coronary artery disease, COPD - Chronic obstructive pulmonary disease, cdiff - clostridium difficile, IBS - Irritable Bowel Syndrome)

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.